Detalhe da pesquisa
1.
Impacts of tumor microenvironment during neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma.
Cancer Sci
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38693726
2.
Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.
Esophagus
; 21(2): 102-110, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240916
3.
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Esophagus
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607538
4.
Influences of intratumoral heterogeneity on assessment of tumor microenvironment in esophageal squamous cell carcinoma.
Cancer Sci
; 114(3): 1180-1191, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36424361
5.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Br J Cancer
; 128(10): 1897-1905, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871043
6.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer
; 129(6): 1032-1039, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532830
7.
The Impact of Pretreatment Esophageal Stenosis on Survival of Esophageal Cancer Patients.
Ann Surg Oncol
; 30(5): 2703-2712, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572808
8.
Survival outcomes of esophageal cancer patients with recurrence after curative treatments.
BMC Cancer
; 23(1): 1051, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37915027
9.
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
BMC Cancer
; 23(1): 726, 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543568
10.
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
BMC Cancer
; 23(1): 779, 2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605122
11.
Survival Impacts of Impaired Lung Functions and Comorbidities on Elderly Esophageal Cancer Patients.
World J Surg
; 47(12): 3229-3239, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37798404
12.
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
Int J Clin Oncol
; 28(6): 756-763, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943545
13.
Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab.
Int J Clin Oncol
; 28(9): 1139-1146, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421478
14.
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Lancet
; 398(10302): 759-771, 2021 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454674
15.
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.
Invest New Drugs
; 40(3): 614-621, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278170
16.
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
BMC Cancer
; 22(1): 711, 2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35765021
17.
Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study.
Int J Colorectal Dis
; 37(6): 1393-1402, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585358
18.
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048.
Int J Clin Oncol
; 27(12): 1805-1817, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264378
19.
Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303).
Esophagus
; 19(4): 702-710, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904643
20.
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study.
Esophagus
; 19(3): 444-451, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050435